COVID-19 Disease in the Paediatric Population: A Cross Sectional Study at the University Teaching Hospital in Port Harcourt, Southern Nigeria
International Journal of TROPICAL DISEASE & Health · pp. 15–20 · Published 17 Apr 2021
10.9734/ijtdh/2021/v42i530454Abstract
Background: Globally, there has been a destruction of human lives, economies and health systems by the novel corona virus pandemic. Presently there is no known certain cure, although a number of vaccines have been proposed to prevent the corona virus disease 2019 (COVID-19) which was first seen as increasing number of pneumonia cases in Wuhan, China, with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) as the causative organism. Objectives: To screen paediatric patients for COVID-19 at the University of Port Harcourt Teaching Hospital and to know their pattern of presentation. Materials and Methods: Descriptive cross-sectional study, not controlled, over a period of six weeks, using interviewer administered structured questionnaire which was adapted and used at the Accident and Emergency Department for patients triaging as a COVID-19 Risk assessment tool. No action was required for a score of 0-7, while admission into COVID-19 holding area following review by IDU was recommended for a score 8 ≥17. All children brought into the department, requiring treatment were screened. Results: There were 131 patients, 74 (56.5%) males and 56 (42.7%) females, with a mean age 7.2 ± 5.41 years. Male: Female ratio was 1.3:1. Four children (3%) had a total score of ≥ 8, while half of them (n=2; 50%) tested positive for COVID-19, giving a disease prevalence of 1.5%. Both cases were females; fever and difficulty in breathing were the commonest symptoms. No mortality was recorded. Conclusions: COVID-19 prevalence is low in children, and they have a good outcome. A community-based study is recommended.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
1
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.